Cronos Group (CRON) vs Orchestra BioMed (OBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Orchestra BioMed (OBIO) has outperformed Cronos Group (CRON) over the past year, gaining 107.3% versus a gain of 23.7%. Over five years, CRON leads with a -40.9% price change compared with -42.5% for OBIO. Cronos Group is the larger company by market cap ($1.19 billion vs $340.2 million), about 3.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRON | OBIO |
|---|---|---|
| Share price | $3.24 | $5.66 |
| Market cap | $1.19B | $340.19M |
| 1-day change | -1.37% | -3.08% |
| YTD return | +23.19% | +36.39% |
| 1-year return | +23.66% | +107.33% |
| 5-year return | -40.88% | -42.54% |
| P/E ratio (TTM) | 17.05 | — |
| EPS (TTM) | $0.19 | $-0.86 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.61 | $6.50 |
| 52-week low | $2.28 | $2.66 |
| Distance from 52-week high | -10.20% | -12.92% |
| Average volume | 1.14M | 299.73K |
| Shares outstanding | 368.41M | 60.11M |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cronos Group is about 3.5 times larger than Orchestra BioMed by market value ($1.19B vs $340.19M).
- OBIO has outperformed CRON by 83.7 percentage points over the past year.
CRON vs OBIO FAQ
Which is bigger, Cronos Group or Orchestra BioMed?
Cronos Group (CRON) is larger, with a market capitalization of $1.19B compared with $340.19M for Orchestra BioMed (OBIO).
Which stock has performed better over the past year, CRON or OBIO?
OBIO returned +107.33% over the past 12 months, compared with +23.66% for CRON (price return, excluding dividends). Past performance does not predict future results.
Are Cronos Group and Orchestra BioMed in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.